Corporate | 9 July 2002 11:24

Biotest AG english

Cooperation of Biotest and Olympus in the US and Canadian Market Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Cooperation of Biotest and Olympus in the US and Canadian Market Dreieich, July 09, 2002. Biotest, a pharmaceutical and diagnostic company located near Frankfurt, Germany, and Olympus America Inc., Melville, New York, have signed a distribution agreement for the US and Canadian Market. The cooperation encompasses marketing and sales of a significant number of the automated blood grouping analyzer (TANGO) and associated reagents after getting the necessary regulatory approvals. Olympus America Inc. is a market leader in automated blood grouping serology in US and Canadian blood banks. The new TANGO analyzer, that was especially designed for the specific needs of the 24 hour operation in hospitals, sets new quality and safety standards and allows Olympus America to penetrate the hospital transfusion market by an ideal line extension. The TANGO automates the complete blood group typing and antibody screening and is also suitable for emergency blood transfusions. The cooperation with a strong distribution partner for Northern America is for Biotest a very important milestone in getting a global market presence with innovative system concepts in transfusion medicine. Biotest AG Board of Managing Directors end of message, (c)DGAP 09.07.2002 ——————————————————————————– WKN: 522720; ISIN: DE0005227201; Index: SDax Listed: Amtlicher Markt in Frankfurt (SMAX), Freiverkehr in Berlin, Düsseldorf, Stuttgart und Hamburg 091124 Jul 02